Thrombosis

What Is Thrombosis?

Thrombosis is the medical term for the formation of a blood clot, called a thrombus, inside a blood vessel where it can obstruct normal blood flow. While clotting is a normal and essential process that stops bleeding after an injury, thrombosis occurs when that same process activates inappropriately inside an intact vessel, creating a blockage rather than sealing a wound.¹

Blood clots can form within arteries, which carry oxygen rich blood away from the heart, or within veins, which return blood back toward the heart. The underlying mechanisms driving clot formation differ meaningfully between these two vessel types, which is why arterial and venous thrombosis are generally treated as distinct clinical problems despite sharing the same basic process.²

Physicians often explain the general principles behind thrombosis using a framework known as Virchow’s triad, first described in the nineteenth century, which identifies three broad conditions that predispose blood to clot abnormally: injury to the vessel wall, an overly active clotting system within the blood itself, and stagnant or slowed blood flow.³

Endothelial injury, hypercoagulability, and stasis are the three mechanisms predisposing to the formation of thrombosis, together known as Virchow’s triad.
National Center for Biotechnology Information

Types of Thrombosis

Arterial thrombosis typically develops at the site of a ruptured or eroded atherosclerotic plaque, forming a platelet rich clot that can rapidly and completely block blood flow through the artery. This process underlies most heart attacks and many strokes, since arteries supplying the heart and brain are particularly vulnerable to plaque related blockage.²

Venous thrombosis, by contrast, more commonly develops in areas of slowed or stagnant blood flow, such as the deep veins of the leg, and produces a clot composed largely of red blood cells trapped within a fibrin mesh. Deep vein thrombosis and the pulmonary embolism it can cause are the most familiar examples of this form.¹

Less common forms of thrombosis can occur in less typical locations, including the veins of the abdomen, the vessels supplying the liver, or the venous sinuses within the brain. Each of these less common presentations tends to involve its own specific combination of underlying risk factors and requires specialized diagnostic evaluation.⁴

Symptoms

Symptoms of thrombosis depend heavily on the location and type of vessel affected. Arterial thrombosis in a coronary artery typically produces chest pain and the other classic symptoms of a heart attack, while arterial thrombosis affecting the brain produces sudden neurological symptoms consistent with a stroke.²

Venous thrombosis in a leg vein commonly causes swelling, pain, warmth, and redness in the affected limb, though as many as half of all cases produce no noticeable symptoms at all. If a piece of the clot breaks free and travels to the lungs, sudden shortness of breath, chest pain, and a rapid heart rate can signal a pulmonary embolism.¹

Because symptoms vary so widely and can sometimes be entirely absent, thrombosis is often identified only through imaging performed for another reason, or after a serious complication such as a heart attack, stroke, or pulmonary embolism has already occurred.¹

Causes

Endothelial injury, the first component of Virchow’s triad, refers to damage to the inner lining of a blood vessel, which can result from surgery, trauma, catheter placement, or the chronic inflammatory process that drives atherosclerosis in arteries.³

Hypercoagulability describes a state in which the blood’s clotting system is more active than normal, which can result from inherited conditions affecting specific clotting proteins, certain cancers, pregnancy, hormone based medications, or a range of acquired medical conditions that shift the body’s natural balance toward clot formation.⁵

Stasis, the third component, refers to slowed or stagnant blood flow, commonly caused by prolonged immobility, such as extended bed rest, long distance travel, or paralysis, along with structural changes in blood vessels that impair normal circulation, such as varicose veins or prior episodes of thrombosis.³

Risk Factors

Risk factors for arterial thrombosis largely mirror the traditional risk factors for atherosclerosis and coronary artery disease, including smoking, high blood pressure, diabetes, elevated cholesterol, obesity, and a family history of early heart disease.²

Risk factors for venous thrombosis include recent surgery, cancer, pregnancy and the weeks following delivery, hormone based contraceptives, inherited clotting disorders, older age, and extended immobility, whether due to hospitalization, injury, or long distance travel.⁵

Certain factors raise risk for both arterial and venous thrombosis simultaneously, including active cancer, certain autoimmune conditions such as antiphospholipid syndrome, and, as documented extensively during the recent global pandemic, severe systemic infections that trigger widespread inflammation and abnormal clotting activity throughout the body.⁶

Complications

The most immediately dangerous complication of thrombosis occurs when a clot, or a piece of one, breaks free and travels through the bloodstream to block a vessel elsewhere, a process called embolism. A clot originating in a leg vein can travel to the lungs and cause a pulmonary embolism, while a clot forming in the heart or a neck artery can travel to the brain and cause a stroke.¹

Even when a clot does not travel, it can cause lasting damage at its original location. Venous thrombosis that resolves incompletely can lead to post thrombotic syndrome, causing chronic pain, swelling, and skin changes in the affected limb, while arterial thrombosis can cause permanent tissue damage in the heart, brain, or limb supplied by the blocked vessel.¹

Both arterial and venous thrombosis carry a meaningful risk of recurrence, particularly in patients whose underlying risk factors, such as an inherited clotting disorder or active cancer, remain present after the initial clotting event has been treated.⁵

Treatment

Treatment approaches differ meaningfully between arterial and venous thrombosis, reflecting their distinct underlying mechanisms. Arterial thrombosis is generally treated with antiplatelet medications, such as aspirin or P2Y12 inhibitors, which work by preventing platelets from clumping together to form or extend a clot.⁷

Venous thrombosis is typically treated with anticoagulant medications instead, which work through a different mechanism, interrupting the coagulation cascade responsible for forming the fibrin mesh that holds a venous clot together. In both cases, more aggressive interventions, including clot dissolving medications or catheter based procedures to physically remove a clot, may be used for severe or life threatening presentations.⁷

Balancing the benefits of these medications against their most significant risk, bleeding, is a central part of thrombosis treatment. Physicians must weigh individual factors such as age, kidney function, prior bleeding history, and other medications a patient takes when determining the safest and most effective treatment regimen.⁷

Prevention

For arterial thrombosis, prevention overlaps substantially with general cardiovascular risk reduction, including managing blood pressure, cholesterol, and diabetes, maintaining regular physical activity, and avoiding tobacco, all of which slow the atherosclerotic process underlying most arterial clots.²

For venous thrombosis, prevention focuses heavily on reducing periods of prolonged immobility, using mechanical compression devices during hospitalization or surgery, and, for patients at elevated risk, using preventive doses of anticoagulant medication during high risk periods such as major surgery or extended hospital stays.⁵

For people already known to have an elevated clotting risk, whether due to an inherited condition, cancer, or a prior thrombotic event, working closely with a physician to determine an appropriate long term prevention strategy is essential to reducing the likelihood of a future clot.⁵

Why Visual Communication Matters for Thrombosis

Thrombosis is a process that happens entirely out of view, inside a blood vessel, and explaining the difference between a platelet rich arterial clot and a fibrin based venous clot, or how a clot can break free and travel to an entirely different part of the body, requires visuals that can show blood flow and clot formation happening in real time.¹

Pharmaceutical companies, hematology and cardiology practices, and patient education organizations rely on clear illustration and animation to explain the biology of thrombosis and the medications used to prevent and treat it.

• Illustrating the differences between arterial and venous clot formation
• Animating Virchow’s triad and how injury, hypercoagulability, and stasis each contribute to clotting
• Explaining the distinct mechanisms of action for antiplatelet and anticoagulant medications
• Visualizing how a clot can embolize and travel to the lungs or brain
• Supporting patient education on recognizing symptoms and understanding personal risk
• Creating training materials for clinicians on balancing clotting and bleeding risk

How Biotic Artlab Supports Thrombosis Communication

We work with pharmaceutical companies, hematology and cardiology practices, and healthcare organizations to create precise, engaging visuals that make the biology of thrombosis understandable for patients, clinicians, and industry audiences alike.

• Custom 3D animations of arterial and venous clot formation
• Detailed illustrations of Virchow’s triad and thrombosis risk factors
• Mechanism of action animations for antiplatelet and anticoagulant therapies
• Patient facing educational materials on clot risk and prevention strategies
• Clinical training content on thrombosis diagnosis and treatment selection
• Conference presentations and marketing visuals for hematology and cardiology audiences

Frequently Asked Questions

What is the difference between arterial and venous thrombosis?

Arterial thrombosis typically forms at a site of ruptured plaque and is composed largely of platelets, underlying most heart attacks and strokes. Venous thrombosis typically forms in areas of slowed blood flow and is composed largely of fibrin and trapped red blood cells, underlying conditions such as deep vein thrombosis.²

What is Virchow’s triad?

Virchow’s triad describes three general conditions that predispose to thrombosis: injury to a blood vessel wall, an overly active clotting system within the blood, and slowed or stagnant blood flow. Most cases of thrombosis involve at least one, and often more than one, of these three factors.³

Why do doctors use different medications for arterial and venous clots?

Arterial and venous clots form through different mechanisms, so they respond best to different types of medication. Antiplatelet drugs target the platelet driven process behind arterial clots, while anticoagulants target the coagulation cascade responsible for venous clots.⁷

Can thrombosis be inherited?

Yes. Several inherited conditions increase the blood’s tendency to clot abnormally, raising the risk of venous thrombosis in particular. People with a strong family history of blood clots are often evaluated for these inherited clotting disorders.⁵

What is the biggest danger of untreated thrombosis?

The greatest immediate danger is embolism, in which part of a clot breaks free and travels to block a vessel elsewhere in the body, potentially causing a pulmonary embolism, stroke, or other serious complication depending on where the clot originated.¹

How is thrombosis diagnosed?

Diagnosis typically involves imaging, such as ultrasound for suspected venous clots or angiography and specialized cardiac imaging for suspected arterial clots, often combined with blood tests that assess clotting activity and rule out other causes of symptoms.¹

Have a Project in Mind? Contact Us.

If you are developing patient education materials, clinical training content, or marketing visuals related to thrombosis or blood clotting disorders, our team can help translate the science into visuals that are both accurate and easy to understand. Contact us at info@biotic-artlab.com or get in touch through our contact form to discuss your project.

References

1. National Center for Biotechnology Information, StatPearls. Thrombosis.
2. National Center for Biotechnology Information. Blood Coagulation and the Risk of Atherothrombosis, A Complex Relationship.
3. National Center for Biotechnology Information, StatPearls. Virchow Triad.
4. National Center for Biotechnology Information. The Pathophysiology of Portal Vein Thrombosis in Cirrhosis, Getting Deeper Into Virchow’s Triad.
5. National Center for Biotechnology Information, StatPearls. Hypercoagulability.
6. National Center for Biotechnology Information. COVID 19 and Venous Thromboembolism, From Pathological Mechanisms to Clinical Management.
7. National Center for Biotechnology Information. Bleeding in Antiplatelet Therapy, A Narrative Review of Clinical Evidence and the Roles of Pharmacists and Nurses.

Disclaimer: This page provides general educational information and is not a substitute for diagnosis, treatment, emergency care, or individualized advice from a qualified healthcare professional.